The FDA adverse-event record for hamster

Hamster Adverse Event Insights

The FDA Center for Veterinary Medicine database holds 8 adverse event reports for Hamster, distributed across 2 distinct breeds currently tracked in the system. Of those reports, 2 involved a death outcome, producing a 25.0% case-fatality rate among reported events, which reflects reporting severity bias rather than true population mortality. These figures are aggregated directly from openFDA's Animal & Veterinary Adverse Events endpoint and update as new voluntary submissions flow through pet owners, veterinarians, and drug manufacturers.

The most frequently reported clinical signs for Hamster are Death (2 reports), Vaginal discharge (2 reports), Lack of efficacy (ectoparasite) - NOS (1 reports), Pruritus (1 reports), with Death leading the reaction traffic at 2 submissions. On the product side, Selamectin is the single most-referenced drug with 3 reports, followed by Ivermectin (1), Silver Sulfadiazine (1), Device: Animal Care (Bowls, Crates, Etc) (1). This combination surfaces which therapeutic classes generate the most adverse event chatter for this species, a useful starting point when comparing Hamster reporting patterns against other companion animals in the dataset.

Of the 8 Hamster reports with a coded outcome, Outcome Unknown accounts for the largest share at 50.0%. Annual submission volume spans 2,014 to 2,022 reports across the 6 years on file, a range that reflects evolving owner awareness, veterinary reporting habits, and new product approvals rather than stable underlying incidence. The breed-level table below breaks these patterns down further, showing how the 2 tracked hamster breeds compare on volume, deaths, and average age at report. As with all FDA adverse event data, correlation is the ceiling, causation requires clinical investigation beyond what these aggregates can provide.